Hexosamine analogs: from metabolic glycoengineering to drug discovery.
Hexosamine analogs: from metabolic glycoengineering to drug discovery.
复制标题
DOI:
10.1016/j.cbpa.2009.08.001
复制
发表时间:
2009-12
影响因子:
7.8
通讯作者:
Yarema, Kevin J.
中科院分区:
文献类型:
--
作者:
Wang, Zhiyun;Du, Jian;Che, Pao-Lin;Meledeo, M. Adam;Yarema, Kevin J.
Metabolic glycoengineering, a technique pioneered almost two decades ago wherein monosaccharide analogs are utilized to install non-natural sugars into the glycocalyx of mammalian cells, has undergone a recent flurry of advances spurred by efforts to make the methodology more efficient. This article describes the versatility of metabolic glycoengineering, which is a prime example of ‘chemical glycobiology,’ and gives an overview of its capability to endow complex carbohydrates in living cells and animals with interesting (and useful!) functionalities. Then an overview is provided describing how acylated monosaccharides, a class of molecules originally intended to be efficiently-used, membrane-permeable metabolic intermediates, have led to the discovery that a subset of these compounds (e.g. tributanoylated hexosamines) display unanticipated ‘scaffold-dependent’ activities; this finding establishes these molecules as a versatile platform for drug discovery.
登录
查看更多内容
影响因子:
7.3
作者:
Elmouelhi N;Aich U;Paruchuri VD;Meledeo MA;Campbell CT;Wang JJ;Srinivas R;Khanna HS;Yarema KJ
通讯作者:
Yarema KJ
影响因子:
7.3
作者:
Campbell CT;Aich U;Weier CA;Wang JJ;Choi SS;Wen MM;Maisel K;Sampathkumar SG;Yarema KJ
通讯作者:
Yarema KJ
影响因子:
4.3
作者:
Collins, BE;Fralich, TJ;Schnaar, RL
通讯作者:
Schnaar, RL
影响因子:
4
作者:
Lavis, Luke D.
通讯作者:
Lavis, Luke D.
DOI:
10.1073/pnas.0707090104
发表时间:
2007-10-23
影响因子:
11.1
作者:
Baskin, Jeremy M.;Prescher, Jennifer A.;Bertozzi, Carolyn R.
通讯作者:
Bertozzi, Carolyn R.